Summary | Excerpt | Reviews | Beyond the book | Read-Alikes | Genres & Themes | Author Bio
Critics' Opinion:
Readers' Opinion:
First Published:
May 2018, 352 pages
Paperback:
Jan 2020, 368 pages
Book Reviewed by:
Kim Kovacs
Buy This Book
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Prologue
November 17, 2006
Tim Kemp had good news for his team.
The former IBM executive was in charge of bioinformatics at Theranos, a startup with a cutting-edge blood-testing system. The company had just completed its first big live demonstration for a pharmaceutical company. Elizabeth Holmes, Theranos’s twenty-two-year-old founder, had flown to Switzerland and shown off the system’s capabilities to executives at Novartis, the European drug giant.
“Elizabeth called me this morning,” Kemp wrote in an email to his fifteen-person team. “She expressed her thanks and said that, ‘it was perfect!’ She specifically asked me to thank you and let you all know her appreciation. She additionally mentioned that Novartis was so impressed that they have asked for a proposal and have expressed interest in a financial arrangement for a project. We did what we came to do!”
This was a pivotal moment for Theranos. The three-year-old startup had progressed ...
Carreyrou's work has won many accolades; his Wall Street Journal articles on Theranos won the George Polk Award for Financial Reporting, and Bad Blood was awarded the Financial Times and McKinsey Business Book of the Year Award. It also appeared on many "best of" lists for 2018. My vote can be added; I certainly found it to be one of the finest non-fiction accounts I've read, and I highly recommend it to those interested in cautionary tales about the business world or great non-fiction reads in general...continued
Full Review
(825 words)
This review is available to non-members for a limited time. For full access,
become a member today.
(Reviewed by Kim Kovacs).
Bethany McLean, bestselling coauthor of The Smartest Guys in the Room and All the Devils Are Here
You will not want to put this riveting, masterfully reported book down. No matter how bad you think the Theranos story was, you'll learn that the reality was actually far worse.As reported in John Carreyrou's book Bad Blood: Secrets and Lies in a Silicon Valley Startup, Elizabeth Holmes's company Theranos produced a device that it claimed could run a medical diagnostic test called an immunoassay on a very small amount of blood.
An assay is a procedure for measuring the amount of, or presence of, a specific substance (an "analyte") in a larger body of material. Assays are used in many fields; for example, a geologist might assay a lump of ore to determine the amount of iron present in it. In medicine, an immunoassay is just one type of assay that might be run to assist in managing an individual's health. A biological sample is obtained from the subject, most often blood, which is then assayed for the presence of...
This "beyond the book" feature is available to non-members for a limited time. Join today for full access.
If you liked Bad Blood, try these:
by Jamie Ducharme
Published 2022
A propulsive, eye-opening work of reporting, chronicling the rise of Juul and the birth of a new addiction.
by Christopher Leonard
Published 2020
Just as Steve Coll told the story of globalization through ExxonMobil and Andrew Ross Sorkin told the story of Wall Street excess through Too Big to Fail, Christopher Leonard's Kochland uses the extraordinary account of how one of the biggest private companies in the world grew to be that big to tell the story of modern corporate America.
The House on Biscayne Bay
by Chanel Cleeton
As death stalks a gothic mansion in Miami, the lives of two women intertwine as the past and present collide.
The Flower Sisters
by Michelle Collins Anderson
From the new Fannie Flagg of the Ozarks, a richly-woven story of family, forgiveness, and reinvention.
The Funeral Cryer by Wenyan Lu
Debut novelist Wenyan Lu brings us this witty yet profound story about one woman's midlife reawakening in contemporary rural China.
Your guide toexceptional books
BookBrowse seeks out and recommends the best in contemporary fiction and nonfiction—books that not only engage and entertain but also deepen our understanding of ourselves and the world around us.
